AlphaFold predicted structure
RASGRP2 · Q7LDG7

Mean pLDDT
77.1/ 100
Confident
609 residues
Confidence breakdown
- Very high(≥ 90)43%
- Confident(70–90)29%
- Low(50–70)11%
- Very low(< 50)17%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
RAS guanyl releasing protein 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
BIALLELIC, autosomal or pseudoautosomalInherited bleeding disorders
BIALLELIC, autosomal or pseudoautosomalOsteopetrosis
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalplatelet-type bleeding disorder 18
Rare hemorrhagic disorder due to a platelet receptor defect
Abnormal platelet aggregation
osteopetrosis
Abnormal bleeding
gout
neurodegenerative disease
Respiratory insufficiency
hereditary disease
Thrombocytopenia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
RAS guanyl-releasing protein 2
Functions as a calcium- and DAG-regulated nucleotide exchange factor specifically activating Rap through the exchange of bound GDP for GTP. May also activate other GTPases such as RRAS, RRAS2, NRAS, KRAS but not HRAS. Functions in aggregation of platelets and adhesion of T-lymphocytes and neutrophils probably through inside-out integrin activation. May function in the muscarinic acetylcholine receptor M1/CHRM1 signaling pathway
RASGRP2 · Q7LDG7

Mean pLDDT
77.1/ 100
Confident
609 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0